Detalles de la búsqueda
1.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer
; 152(2): 267-275, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005450
2.
Effectiveness of biologics in Australian patients with rheumatoid arthritis: a large observational study: REAL.
Intern Med J
; 48(10): 1185-1192, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29968400
3.
Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications.
Scand J Gastroenterol
; 50(4): 462-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25623641
4.
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
J Gastroenterol Hepatol
; 29(7): 1458-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25587616
5.
A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice.
PLoS One
; 19(1): e0294847, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271438
6.
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection.
J Hepatol
; 58(3): 467-72, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23183524
7.
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Lancet
; 379(9813): 315-21, 2012 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22226517
8.
Living With Hereditary Angioedema in Australia: Findings From a National Observational Study Using Short Message Service to Monitor the Burden of Disease.
J Allergy Clin Immunol Pract
; 11(8): 2457-2467.e1, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36918098
9.
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.
Breast Cancer Res Treat
; 134(2): 617-24, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22678156
10.
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.
Sci Rep
; 12(1): 10210, 2022 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715644
11.
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.
Am J Surg Pathol
; 45(8): 1108-1117, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232604
12.
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset.
J Rheumatol
; 47(8): 1174-1181, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31787605
13.
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
Hepatology
; 47(2): 428-34, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18220290
14.
Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies.
Rheumatol Ther
; 6(2): 231-243, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859494
15.
Reply to: "Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection".
J Hepatol
; 59(1): 194-5, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23500151
16.
A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
Int J Rheum Dis
; 21(8): 1581-1590, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205926
17.
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies.
Lung Cancer
; 126: 1-8, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30527172
18.
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
N Engl J Med
; 351(12): 1206-17, 2004 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-15371578
19.
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION Study.
JAMA Oncol
; 2(3): 305-12, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26720423
20.
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.
Asia Pac J Clin Oncol
; 11(1): 4-14, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24575793